Superluminal secures $60M for Phase 1 of genetic obesity drugnews2026-09-03T10:00:59+00:00September 3rd, 2026|Endpoints News|
GSK to license Hutchmed’s KRAS-EGFR cancer drug for $110M upfrontnews2026-09-03T09:59:27+00:00September 3rd, 2026|Endpoints News|
South African scientists could face year in prison unless registered with national standards body, under proposed lawnews2026-09-03T08:30:00+00:00September 3rd, 2026|Chemistry World|
Symrise signs agreement to divest its Terpene Ingredients business to Mutares SE & Co. KGaAnews2026-09-03T05:32:19+00:00September 3rd, 2026|chemeurope.com|
Precise Characterization of Black Masses as the Key to Efficient Battery Recyclingnews2026-09-03T05:32:15+00:00September 3rd, 2026|chemeurope.com|
Polyblend confirms €4 million investment to accelerate the production of compounds based on recycled plasticsnews2026-09-03T05:32:14+00:00September 3rd, 2026|chemeurope.com|